Skandinaviska Enskilda Banken AB publ purchased a new position in shares of Arconic during the first quarter worth $1,263,000. Vanguard Group Inc. now owns 41,877,016 shares of the basic materials company's stock valued at $1,103,040,000 after buying an additional 1,559,763 shares in the last quarter. DAVENPORT & Co LLC's holdings in Arconic were worth $514,000 as of its most recent SEC filing.
Institutional investors have recently made changes to their positions in the stock. Cleararc Capital Inc. raised its position in Arconic by 1.3% in the first quarter. Condor Capital Management now owns 32,441 shares of the basic materials company's stock valued at $855,000 after buying an additional 9,682 shares during the period. Achmea Investment Management B.V. purchased a new position in Arconic during the first quarter worth approximately $2,581,000.
Other hedge funds also recently bought and sold shares of the company. Finally, Quantitative Investment Management LLC increased its stake in shares of Arconic by 21.7% in the first quarter. Finally, Covington Capital Management purchased a new position in shares of Arconic during the first quarter worth $710,000. Advantus Capital Management Inc now owns 44,275 shares of the basic materials company's stock worth $1,166,000 after buying an additional 546 shares during the period. Quantitative Investment Management LLC now owns 441,800 shares of the basic materials company's stock valued at $11,637,000 after buying an additional 78,700 shares during the period.
Arconic (NASDAQ ARNC) traded up 2.29% during mid-day trading on Tuesday, hitting $23.66. The rating was maintained by Cowen & Co with "Hold" on Monday, June 26. Arconic has $25.0 highest and $19 lowest target.
Arconic (NASDAQ:ARNC) last issued its quarterly earnings results on Tuesday, April 25th. After $0.33 actual earnings per share reported by Arconic Inc for the previous quarter, Wall Street now forecasts -15.15 % negative EPS growth. Arconic had a net margin of 10.09% and a return on equity of 23.34%. The business had revenue of $3.06 billion for the quarter, compared to the consensus estimate of $3 billion. The firm's revenue for the quarter was down 4.3% on a year-over-year basis. Analysts expect next quarter's EPS will be $0.28 with next year's EPS anticipated to be $1.51.
UK Government orders inquiry into contaminated blood scandal
Much of the plasma used to make the product came from donors such as prison inmates in the United States , who sold their blood. Theresa May told the Cabinet that she and Health Secretary Jeremy Hunt had decided an investigation was needed.
WARNING: This piece of content was reported by Chaffey Breeze and is the property of of Chaffey Breeze. If you are accessing this news story on another website, it was illegally copied and republished in violation of United States & worldwide copyright & trademark law. The original version of this piece of content can be viewed at https://www.chaffeybreeze.com/2017/07/10/arconic-inc-nasdaqarnc-upgraded-at-j-p-morgan-chase-co.html.
Several other equities analysts have also issued reports on the company. Morgan Stanley reissued an "equal weight" rating and set a $28.00 target price on shares of Arconic in a research note on Tuesday, June 13th. Cowen and Company restated a "market perform" rating and set a $25.00 price objective on shares of Arconic in a research note on Wednesday, March 29th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and five have assigned a buy rating to the stock. The company presently has an average rating of "Hold" and an average price target of $26.70.
In related news, Director Patrice E. Merrin bought 10,000 shares of Arconic stock in a transaction dated Tuesday, May 30th. Following the purchase, the director now owns 5,000 shares in the company, valued at $135,850. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
In other Arconic news, Director Christopher L. Ayers purchased 7,325 shares of the stock in a transaction on Friday, May 26th. The shares were bought at an average cost of $27.31 per share, with a total value of $200,045.75. Following the acquisition, the director now directly owns 7,425 shares in the company, valued at $202,776.75.
- JP Morgan Chase & Co (JPM) Shares Gap Up Following Analyst Upgrade
- Syria Monitor Says IS Chief Abu Bakr al-Baghdadi Dead
- Rhumbline Advisers Increases Position in Costco Wholesale Corporation (NASDAQ:COST)
- Afrique Préparatifs Elim CHAN 2018: Le Togo encore battu en amical
- Affaire de la sex-tape de Valbuena: Benzema obtient gain de cause
- Renault: célèbre le millionième véhicule produit à Tanger
- Ces joueurs d’origine africaine évoluant pour des nations européennes
- Temasek Reports Record Net Portfolio Value Of S$275 Bln
- Physicians Realty Trust (NYSE:DOC) Shares Bought by Geode Capital Management LLC
- Govt calls for public consultation on proposed Cybersecurity Bill